Skip to Main Content

Paper Details

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
N Engl J Med
381
2018
Author NameAffiliation
David C WedgeFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Gunes GundemFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Sarah O'MearaFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Jon TeagueFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Adam ButlerFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Charlie E MassieFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Moritz GerstungFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
Peter J CampbellFrom the Wellcome-MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research (J.G., University of Cambridge (J.G., Cambridge University Hospitals NHS Foundation Trust (J.G., Wellcome Trust Sanger Institute, European Bioinformatics Institute (R.C., Big Data Institute, University of Oxford, Queen's University Belfast, Guy's and St. Thomas' NHS Foundation Trust, London (C.N.H.) - all in the United Kingdom the Center for Molecular Oncology and the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Zealand University Hospital, and the University of Copenhagen, H.C.H.) and the Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence
  • 1 - 8

Datasets